Serological TK1 predict pre-cancer in routine health screenings of 56,178 people

Author:

Wang Yu11,Jiang Xiaorong11,Wang Shasha2,Yu Haixia1,Zhang Tingting1,Xu Shuan3,Li Wenlong3,He Ellen3,Skog Sven3

Affiliation:

1. Health Management Center, PLA 180 Hospital, Quanzhou, Fujian, China

2. Department of Disease Prevention and Control, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujian, China

3. Sino-Swed Molecular Bio-Medicine Research Institute, Shenzhen, Guangdong, China

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference26 articles.

1. World Health Statistics 2017, in: Monitoring Health for the SDGs, Sustainable Development Goals, ISBN 978-92-4-156548-6 © World Health Organization 2017, p. 31.

2. Cancer burden in China from 2006 to 2010;Zhang;Int J Clin Exp Pathol,2015

3. Report of cancer incidence and mortality in China, 2010;Chen;Ann Transl Med,2014

4. Serum TK1 is a more reliable marker than CEA and AFP for cancer screening in a study of 56286 people;Wang;Cancer Biomark,2016

5. B.W. Stewart and Ch.P. Wild, World Cancer Report, 2014, ISBN 978-92-832-0429-9.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3